Clinical trials sponsored by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase breakdown

Conditions studied

Recruiting trials led by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

• 5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.
  NCT04689347 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 3 locations
• APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch
  NCT05550961 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Duodenal Polyposis Classification in FAP
  NCT07199127 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy
  NCT05537922 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Liver Transplantation for Unresectable Intrahepatic Colangiocarcinoma After Sustained Response to Neoadjuvant Treatments
  NCT06862934 · Phase: Not specified · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Multimodal Approach in Patients With mHSPC. Randomized Trial of APA+ADT vs APA-ADT and Local Treatment
  NCT05649943 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 3 locations
• Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study
  NCT06805812 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 24 locations
• Preoperative Chemoradiotherapy With CApecitabine and Temozolomide in MGMT Silenced, MSS, Locally Advanced RecTal Cancer
  NCT05136326 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Quantifying Systemic Immunosuppression to Personalize Cancer Therapy
  NCT05621837 · Phase: Not specified · Ages: 18 Years to 90 Years · Sex: All (male and female) · 1 location
• RADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 Study
  NCT07030569 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location

Common questions

How many trials is Fondazione IRCCS Istituto Nazionale dei Tumori, Milano recruiting for?

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano is the lead sponsor of 10 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.